Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome

Psychopharmacology

Volumn 124, Issue 3, 1996, Pages 226-230

  Natelson, Benjamin H ^a   Cheu, Joseph ^b   Pareja, Jacqueline ^a   Ellis, Steven P ^b   Policastro, Theresa ^a   Findley, Thomas W ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b KESSLER INSTITUTE FOR REHABILITATION   (United States)

Author keywords

Autonomic dysregulation; Fatigue; MAO inhibitors; Sympathetic

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; PHENELZINE; PLACEBO;

ADULT; ANALGESIA; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HUMAN; MALE; MOOD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC TONE;

ADULT; DOUBLE-BLIND METHOD; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MALE; MONOAMINE OXIDASE INHIBITORS; PHENELZINE;

EID: 0029983445     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246661     Document Type: Article

References (23)

1. Alfonso GR, Chase GD, Cribson MR, Granberg B, Harvey SC, King RE, Martin AN, Medwick T, Swinyard EA, Zink GL (eds) (1985) Remington's pharmaceutical sciences, 17th edn. Mack Publishing, Easton, Pa, pp 908-1097
2. Agarwal SK, Calaresu FR (1993) Supramedullary inputs to cardiovascular neurons of rostral ventrolateral medulla in rats. Am J Physiol 265:111-116
3. Efron B, Tibshirani T (1993) Permutation tests. In: An introduction to the bootstrap. Chapman & Hall, New York, pp 202-219
4. Friedberg F, Krupp LB (1994) A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clin Infect Dis 18 [Suppl 1]:S105-S110
5. Fukuda K, Straus SE, Hickie I, Sharpe MC, Komaroff A, Schluederberg A, Jones JF, Lloyd AR, Wessely S, Gantz NG, Holmes GP, Steele L, Reyes M, Abbey S, Rest J, Jolson H, Peterson DL, Vercoulen JHMM, Tirelli U, Evengard B, Natelson BH, Reeves WC (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Int Med 121:953-959
6. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE et al. (1988) Chronic fatigue syndrome: a working case definition. Ann Int Med 108:387-389
7. Jette AM, Davies AR, Clearly PD, Calkins DR, Rubenstein LV, Find A, Kosecoff J, Young RT, Brook RH, Delbanco TL (1988) The functional status questionnaire reliability and validity when used in primary care. J Gen Int Med 1:143-149
8. Komaroff AL, Buchwald D (1991) Symptoms and signs of chronic fatigue syndrome. Rev Infec Dis 13:S8-S11
9. Lane TJ, Manu P, Matthews DA (1991) Depression and somatization in the chronic fatigue syndrome. Am J Med 91:335-344
10. Marcus S, Robins LN, Bucholz K (1990) Quick Diagnostic Interview Schedule 3R version 1. Washington University School of Medicine, St. Louis, mo.
11. McNair DM, Lorr M, Droppleman LF (1971) Profile of mood states: manual. Educational and Industrial Testing Service, San Diego
12. Melia KR, Rasmussen K, Terwilliger RZ, Haycock JW, Nestler EJ, Duman RS (1992) Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments. J Neurochem 58:494-502
13. Miyawaki T, Kawamura H, Hara K, Suzuki K, Usui W, Yasugi T (1993) Differential regional hemodynamic changes produced by the L-glutamate stimulation of the locus coeruleus. Brain Res 600:50-62
14. Natelson BH, Johnson SK, DeLuca J, Sisto S, Ellis SP, Hill N, Bergen MT (1995) Reducing heterogeneity in the chronic fatigue syndrome: a comparison with depression and multiple sclerosis. Clin Infect Dis 21:1204-1210
15. Onghena P, Van Houdenhove B (1992) Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 49:205-219
16. Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK (1993) A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatr Clin Neurosci 5:200-205
17. Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1:385-401
18. Rickels K, Chung HR, Csanalosi IB, Hurowitz AM, London J, Wiseman K, Kaplan M, Amsterdam JD (1987) Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. Arch Gen Psychiatry 44:862-866
19. Schulberg H, Saul M, McClelland M, Ganguli M, Christy W, Frank R (1985) Assessment of depression in primary medical and psychiatric practices. Arch Gen Psychiatry 42:1164-1170
20. Shorter E (1992) From paralysis to fatigue - a history of psychosomatic illness in the modern era. Free Press, New York, N.Y.
21. Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM, Hallahan C, Henle W (1988) Acyclovir treatment of the chronic fatigue syndrome. N Engl J Med 319:1692-1698
22. USP-DI (1990) United States pharmacopeial drug information for health care professionals. US Pharmacopeial Convention, Rockville, MD, pp 2374-2377
23. Valentino RJ, Curtis AL (1991) Antidepressant interactions with corticotropin releasing factor in the noradrenergic nucleus locus coeruleus. Psychopharmamol Bull 27:263-269